secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0000950170-22-011812
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharma stockholders elect three Class I directors and ratify E&Y as auditor
--------------------------------------------------------------------------------

- Carl Gordon, Hongbo Lu, and Ann Taylor elected as Class I directors, each with majority votes.
- Gordon received 18,623,269 votes for (2,386,359 withheld); Lu received 16,687,573 for (4,322,055 withheld).
- Taylor received 20,998,888 votes for (10,740 withheld); broker non-votes of 1,626,573 on all director elections.
- Ernst & Young ratified as auditor for FY2022 with 22,635,538 votes for, 363 against, 300 abstentions.
- Meeting held June 16, 2022; record date April 22, 2022 with 25,269,271 shares entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017022011812/0000950170-22-011812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017022011812/tern-20220616.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer